Wegovy is also approved to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with obesity or overweight and known heart disease
Diarrhoea associated with weight loss injections typically occurs during the initial weeks of treatment or following dose escalation
In addition to the polyphenolic compounds structure, the pH or ion form (Fe 2+ and Fe 3+ ) influences both binding strength and total ion concentration
PLoS ONE 18(1):e0278685 Ferhatbegovi L, Mri D, Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases
These reports can play a critical role in improving drug safety
Contact your GP if symptoms significantly impact quality of life or prevent medication intake